Faron Pharmaceuticals Oy Notification of Major Interest in Shares (0225M)
07 October 2016 - 11:41PM
UK Regulatory
TIDMFARN
RNS Number : 0225M
Faron Pharmaceuticals Oy
07 October 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------------------------------------------------------------
1. Identity of the issuer or Faron Pharmaceuticals Oy
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------- -------------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
--------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
-------------------------------------------------------------------------------------------------- ----
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
-------------------------------------------------------------------------------------------------- ----
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
-------------------------------------------------------------------------------------------------- ----
An event changing the breakdown of voting rights
-------------------------------------------------------------------------------------------------- ----
Other (please Disclosure as per Company's Articles Yes
specify): of Association
------------------------------------------------------- ----------------------------------------- ----
3. Full name of person(s) City Financial Investment
subject to the Company Limited, acting as
notification obligation: Investment Manager and Authorised
(iii) Corporate Director of the
City Financial Absolute Equity
Fund
--------------------------------------------------------- ---------------------------------------------
4. Full name of shareholder(s) BNY Mellon Trust and Depositary
(if different from 3.):(iv) as Trustee to the City Financial
Absolute Equity Fund
--------------------------------------------------------- ---------------------------------------------
5. Date of the transaction 21.9.2016
and date on
which the threshold is
crossed or
reached: (v)
--------------------------------------------------------- ---------------------------------------------
6. Date on which issuer 4.10.2016
notified:
--------------------------------------------------------- ---------------------------------------------
7. Threshold(s) that is/are Above 3%, 3.80%
crossed or
reached: (vi, vii)
--------------------------------------------------------- ---------------------------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation Resulting situation after the triggering
of previous transaction
shares to the triggering
transaction
if possible
using
the ISIN
CODE
-------------- -------------------------------- --------------------------------------------------------------------
Number Number Number Number of voting % of voting
of of of shares rights rights (x)
Shares Voting
Rights
-------------- --------------- --------------- ------------- -------------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
-------------- ----------- ----------- ------------- ------------ ------------ ------------ -----------
Ordinary
Shares
FI40000153309 zero zero 1,000,000 1,000,000 zero 3.80% zero
-------------- --------------- --------------- ------------- ------------ ------------ ------------ -----------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion rights that rights
(xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
------------------ --------------- ---------------------------- ---------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
---------------- --------------- --------------- ----------- ---------------------------- -----------------------
Nominal Delta
---------------- --------------- --------------- ----------- ---------------------------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
--------------------------------------------------------------- -----------------------------------------------------
1,000,000 3.80%
--------------------------------------------------------------- -----------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
----------------------------------------------------------------------------------------------------
The voting rights are managed and controlled by City
Financial Investment Company Limited, Investment manager
and ACD to the City Financial Absolute Equity Fund.
Proxy Voting:
----------------------------------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------- -------------------------------------
11. Number of voting rights proxy
holder will cease
to hold:
------------------------------------------------------------- -------------------------------------
12. Date on which proxy holder will
cease to hold
voting rights:
------------------------------------------------------------- -------------------------------------
13. Additional information: Notification using the total
voting rights figure of 26,311,704
------------------------------------------------------------- -------------------------------------
14. Contact name: Chris Sturdee
------------------------------------------------------------- -------------------------------------
15. Contact telephone number: +44 (0)20 7726 9869
------------------------------------------------------------- -------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLBDBDGGSGBGLR
(END) Dow Jones Newswires
October 07, 2016 08:41 ET (12:41 GMT)
Faron Pharmaceuticals Oy (LSE:FARN)
Historical Stock Chart
From Mar 2024 to May 2024
Faron Pharmaceuticals Oy (LSE:FARN)
Historical Stock Chart
From May 2023 to May 2024
